Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo.
about
Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cellsTRAIL in cancer therapy: present and future challenges.A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection.Proteasome inhibition causes regression of leukemia and abrogates BCR-ABL-induced evasion of apoptosis in part through regulation of forkhead tumor suppressors.killerFLIP: a novel lytic peptide specifically inducing cancer cell death.TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment.The interruption of PKC-ι signaling and TRAIL combination therapy against glioblastoma cells.Regulatory functions of TRAIL in hematopoietic progenitors: human umbilical cord blood and murine bone marrow transplantation.TRAIL-NP hybrids for cancer therapy: a review.Functional implication of TRAIL -716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor.Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced mitochondrial pathway to apoptosis and caspase activation is potentiated by phospholipid scramblase-3.
P2860
Q33705623-00A7748F-FAFE-4B87-A2BD-E54E4290AD7DQ34291312-62F8F31B-469C-459F-9F67-1401D7360243Q34312127-25DEFACD-F94D-4419-AA6A-A9669F2E3A1EQ36737913-95058972-3AC2-43C1-918A-04F9AC0A91ABQ37390575-E4CAF4F1-1A2C-4D7A-9412-9A7941B62FD9Q37577463-DB56B13A-459C-4B51-842F-68BC360410FEQ37972139-8405697C-BCB1-4849-9301-280CBE5A09B0Q38981224-C10D6D03-26FD-461B-A08E-C449A1379F36Q39256130-2158CD1D-559B-4980-9008-E811288FA086Q39263297-5F7E052F-F888-4C00-B219-DEDA50D10D20Q39707551-B5555B5B-055C-4C99-AF63-9ADEC86B5244Q42425074-98E3202B-489F-4E13-9FFB-BA975CCCBCE9
P2860
Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Transduction of tumor necrosis ...... yngeneic tumor growth in vivo.
@ast
Transduction of tumor necrosis ...... yngeneic tumor growth in vivo.
@en
Transduction of tumor necrosis ...... yngeneic tumor growth in vivo.
@nl
type
label
Transduction of tumor necrosis ...... yngeneic tumor growth in vivo.
@ast
Transduction of tumor necrosis ...... yngeneic tumor growth in vivo.
@en
Transduction of tumor necrosis ...... yngeneic tumor growth in vivo.
@nl
prefLabel
Transduction of tumor necrosis ...... yngeneic tumor growth in vivo.
@ast
Transduction of tumor necrosis ...... yngeneic tumor growth in vivo.
@en
Transduction of tumor necrosis ...... yngeneic tumor growth in vivo.
@nl
P2093
P2860
P1433
P1476
Transduction of tumor necrosis ...... syngeneic tumor growth in vivo
@en
P2093
Nordine Benhaga
Roya Khosravi-Far
P2860
P304
P356
10.1158/0008-5472.CAN-05-3501
P407
P577
2006-06-01T00:00:00Z